Health Care · Pharmaceutical Preparations · OTC · CIK 1644963 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.25Day −29.74%Mkt cap $1M1Y −45.0%Off 52W high −74.2%Vol (1Y) 207.5%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,144 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover1.0d |
| Next report (est.)2026-08-07 |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
| Sales (TTM)$1.4M |
| Earnings (TTM)-$1.8M |
| ROE−125.7% |
| Net margin−207.2% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−63.2% |
| 1Y−45.0% |
| 3Y−99.7% |
| 5Y−100.0% |
| Since incept. (ann.)−68.6% |
Price return through 2026-07-30 · series begins 2017-06-27. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)207.5% |
| Ann. volatility (3Y)176.4% |
| Sharpe (1Y)0.67 |
| Sharpe (3Y)−0.26 |
| Max drawdown (1Y)−83.8% |
| Max drawdown (3Y)−99.8% |
| Beta (3Y vs SPY)2.94 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for ATXI.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2025-09-30 | 2025-11-13 | — | — | $0 | — |
| 2025-06-30 | 2025-08-14 | — | — | $1.4M | — |
| 2024-09-30 | 2024-11-14 | — | — | $0 | — |
| 2024-06-30 | 2024-08-09 | — | — | $0 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-07 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
